VCRE
Vicore Pharma Holding ABMarket Cap
$4.57B
Shares
281,525,593
No Price Data
No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Limited data
Not enough data for a confident read.
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50/200-day averages unavailable
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
◦
Short interest
No short-interest data
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VCRE
this stock
Vicore Pharma Holding AB
|
$4.57B | — | — | — | — |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding